.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A review of 194 patients with unexplained chronic dyspnea evaluated the diagnostic contribution of cardiopulmonary exercise testing after routine resting cardiopulmonary assessment had failed to identify a clear cause. CPET helped classify patients according to different physiologic mechanisms, including deconditioning, inappropriate hyperventilation, gas-exchange disorders and cardiovascular abnormalities. A substantial proportion of patients had either deconditioning or hyperventilation-related patterns rather than an unrecognized primary lung disease. The study illustrates why exertional symptoms may require an exercise-based assessment when resting spirometry, imaging and cardiac tests are unrevealing. For clinicians, CPET is most useful when it answers a specific question: is exercise limitation driven predominantly by pulmonary mechanics, gas exchange, cardiovascular response, dysfunctional breathing or poor conditioning? This is directly aligned with the NAPCON PFT and exercise physiology sessions, particularly the emphasis on CPET for unexplained dyspnoea. The paper also supports an important management principle: when deconditioning is the dominant mechanism, pulmonary rehabilitation and structured exercise may be more useful than repeated diagnostic testing or unnecessary medication escalation.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of 194 patients with unexplained chronic dyspnea evaluated the diagnostic contribution of cardiopulmonary exercise testing after routine resting cardiopulmonary assessment had failed to identify a clear cause. CPET helped classify patients according to different physiologic mechanisms, including deconditioning, inappropriate hyperventilation, gas-exchange disorders and cardiovascular abnormalities. A substantial proportion of patients had either deconditioning or hyperventilation-related patterns rather than an unrecognized primary lung disease. The study illustrates why exertional symptoms may require an exercise-based assessment when resting spirometry, imaging and cardiac tests are unrevealing. For clinicians, CPET is most useful when it answers a specific question: is exercise limitation driven predominantly by pulmonary mechanics, gas exchange, cardiovascular response, dysfunctional breathing or poor conditioning? This is directly aligned with the NAPCON PFT and exercise physiology sessions, particularly the emphasis on CPET for unexplained dyspnoea. The paper also supports an important management principle: when deconditioning is the dominant mechanism, pulmonary rehabilitation and structured exercise may be more useful than repeated diagnostic testing or unnecessary medication escalation.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
